Anticarcinogenic efficacy of phytic acid extracted from rice bran on azoxymethane-induced colon carcinogenesis in rats

Experimental and Toxicologic Pathology

Volumn 62, Issue 3, 2010, Pages 259-268

  Norazalina, S ^a   Norhaizan, M E ^a   Hairuszah, I ^a   Norashareena, M S ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Aberrant crypt foci; Azoxymethane; Colon cancer; Phytic acid; Rice bran

Indexed keywords

AZOXYMETHANE; PHYTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; CANCER INHIBITION; CANCER RISK; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; DYSPLASIA; HISTOPATHOLOGY; HYPERPLASIA; MALE; NONHUMAN; ORGAN WEIGHT; RAT; RICE BRAN;

ANIMALS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; CARCINOGENS; COLONIC NEOPLASMS; DIETARY FIBER; MALE; ORYZA SATIVA; PHYTIC ACID; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 77952890136     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2009.04.002     Document Type: Article

References (45)

1. Baten A., Ullah A., Tomazik V.J., Fabian D., Shamsuddin A.M. Inositol-phosphate-induced enhancement of natural killer cell activity correlates with tumor suppression. Carcinogenesis 1989, 10:1595-1598.
2. BERNAS (PadiBeras Nasional Berhad). Annual report 2007. http://www.bernas.com.my.
3. Bird R.P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Letters 1995, 93:55-71.
4. Bird R.P. Aberrant crypt foci to study cancer preventive agents in the colon. Tumor marker protocol 1998, 465-474. Human Press Inc., New Jersey, USA. M. Hanaucek, Z. Walaszek (Eds.).
5. Bird R.P., Good C.K. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicology Letters 2000, 112-113:395-402.
6. Bird C.L., Witte J.S., Swendseid M.E., Shikany J.M., Hunt I.F., Frankl H.D., et al. Plasma ferritin, iron intake, and the risk of colorectal polyps. American Journal of Epidemiology 1996, 144:34-41.
7. Challa A., Rao D.R., Reddy B.S. Interactive suppression of aberrant crypt foci induced by azoxymethane in rat colon by phytic acid and green tea. Carcinogenesis 1997, 18:2023-2026.
8. Corpet D.E., Tache S. Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutrition and Cancer 2002, 43(1):1-21.
9. Englyst H.N., Bingham S.A., Wiggins H.S., Southgate D.A., Seppanen R., Helms P., Anderson V., Cummings J.H. Nonstarch polysaccharide consumption in four Scandinavian populations. Nutrition and Cancer 1982, 4:50-60.
10. Exon J.H., Smith E.H. The effects of sphingomyelin on aberrant colonic crypt foci development, colon crypt cell proliferation and immune function in an aging rat tumor model. Food and Chemical Toxicology 2003, 41:471-476.
11. Ferguson L.R., Harris P.J. Studies on the role of specific dietary fibers in protection against colorectal cancer. Mutation Research 1996, 350:173-184.
12. Fox C.H., Eberl M. Phytic acid (IP6), novel broad spectrum anti-neoplastic agent: a systematic review. Complementary Therapies in Medicine 2002, 10:229-234.
13. Fruhbeck G., Alonso R., Marzo F., Santidrian S.A. Modified method for the indirect quantitative analysis of phytate in foodstuff. Analytical Biochemistry 1995, 225:206-212.
14. Graf E., Eaton J.W. Dietary suppression of colonic cancer: fiber or phytate?. Cancer 1985, 56:717-718.
15. Graf E., Eaton J.W. Antioxidant functions of phytic acid. Free Radical Biology and Medicine 1990, 61-69.
16. Harland B.F., Oberleas D. Phytate in foods. World Review on Nutrition and Dietetics 1987, 52:235-259.
17. Henderson S.M., Perry R.L. Agricultural process engineering 1976, Westport, CT: AVI Publishing.
18. Hu W., Wells J.H., Shin T.S., Godber Comparison of isopropanol and hexane for extraction of vitamin E and oryzanols from stabilized rice bran. Journal of the American Oil Chemists' Society 1996, 12:1653-1656. 73.
19. Jariwalla R.J. Rice-bran products: phytonutrients with potential applications in preventive and clinical medicine. Drugs under Experimental and Clinical Research 2001, 27:17-26.
20. Jariwalla R.J., Sabin R., Lawson S., Bloch D.A., Prender M., Andrews V., et al. Effects of dietary phytic acid (phytate) on the incidence and growth rate of tumors promoted in Fisher rats by a magnesium supplement. Nutrition Research 1988, 8:813-827.
21. Lakkakula N.R., Lima M., Walker T. Rice bran stabilization and rice bran oil extraction using ohmic heating. Bioresource Technology 2004, 92:157-161.
22. McLellan E.A., Medline A., Bird R.P. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Research 1991, 51:5270-5274.
23. Nelson R.L., Yoo S.J., Tanure J.C., Andrianopoulos G.Misumi The effect of iron on experimental colorectal carcinogenesis. Anticancer Research 1989, 9:1477-1482.
24. Nucci M.R., Robinson C.R., Longo R., Campbell P., Hamilton S.R. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Human Pathology 1997, 28:1396-1407.
25. Papanikolaou A., Wang Q.-S., Papanikolaou D.E., Whiteley H.W., Rosenberg D. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. Carcinogenesis 2000, 21:1567-1572.
26. Pretlow T.P., O'Riordan M.A., Somich G.A., Amini S.B., Pretlow T.G. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 1992, 13:1509-1512.
27. Ramezanzadeh F.M., Rao R.M., Windhauser M., Prinyawiwatkul R.T., Marshall W.E. Prevention of hydrolytic rancidity in bran during storage. Journal of Agricultural and Food Chemistry 1999, 47:3050-3052.
28. Rao P.S., Liu X., Das D.K., Weinstein G.S., Tyras D.H. Protection of ischemic heart from reperfusion injury by myo-inositol hexaphosphate a natural antioxidant. The Annals of Thoracic Surgery 1991, 52:908-912.
29. Reddy B.S. Prevention of colon carcinogenesis by components of dietary fiber. Anticancer Research 1999, 19:3681-3683.
30. Reddy B.S., Hirose Y., Cohen L.A., Simi B., Cooma I., Rao C.V. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: Implications for human colon cancer prevention. Cancer Research 2000, 60:4792-4797.
31. Shamsuddin A.M., Ullah A. Inositol hexaphosphate inhibits large intestine cancer in F344 rats 5 months after induction by azoxymethane. Carcinogenesis 1989, 10:625-626.
32. Shamsuddin A.M., Ullah A., Chakravarthy A. Inositol and inositol hexaphosphate suppress cell proliferation and tumor formation in CD-1 mice. Carcinogenesis 1989, 10:1461-1463.
33. Shamsuddin A.M., Baten A., Lalwani N.D. Effect of inositol hexaphosphate on growth and differentiation in K562 erythroleukemia cell line. Cancer Letters 1992, 64:195-202.
34. Shamsuddin A.M., Yang G.Y. Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells. Carcinogenesis 1995, 16:1975-1979.
35. Shamsuddin A.M. Anti-cancer function of phytic acid. International Journal Food Science Technology 2002, 37:769-782.
36. Shamsuddin A.M., Vucenik I. Mammary tumor inhibition by IP 6: a review. Anticancer Research 1999, 19:3671-3674.
37. 6 and inositol in cancer prevention and therapy. Current Cancer Therapy Review 2005, 1:259-269.
38. Shamsuddin A.M., Elsayed A.M., Ullah A. Suppression of large intestinal cancer in F344 rats by inositol hexaphosphate. Carcinogenesis 1988, 9:577-580.
39. Shih C.-K., Chiang W., Kuo M.-L. Effects of adlay on azoxymethane-induced colon carcinogenesis in rats. Food and Chemical Toxicology 2004, 42:1339-1347.
40. Shpitz B., Bomstein Y., Kariv N., Shalev M., Buklan G., Bernheim J. Chemopreventive effect of aspirin on growth of aberrant crypt foci in rats. International Journal of Colorectal Disease 1996, 13:169-172.
41. Takayama T., Katsuki S., Takahashi Y., Ohi M., Nijiri S., Sakamaki S., et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. New England Journal of Medicine 1998, 339:1277-1284.
42. Thompson L.U. Potential health benefits and problems associated with antinutrients in foods. Food Research International 1993, 26:131-149.
43. Ullah A., Shamsuddin A.M. Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats. Carcinogenesis 1990, 11:2219-2222.
44. 6): apoptosis as a possible mechanism of action. Lebensmittel-Wissenschaft & Technologie 2006, 39:1093-1098.
45. Vucenik I., Yang G.Y., Shamsuddin A.M. Inositol hexaphosphate and inositol inhibit DMBA-induced rat mammary cancer. Carcinogenesis 1995, 16:1055-1058.